Woodmont Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $654K | Buy |
1,805
+5
| +0.3% | +$1.71K | 0.04% | 169 |
|
|
2026
Q1 | $633K | Sell |
1,800
-25
| -1% | -$8.91K | 0.04% | 173 |
|
|
2025
Q4 | $597K | Sell |
1,825
-75
| -4% | -$23.8K | 0.04% | 170 |
|
|
2025
Q3 | $536K | Sell |
1,900
-30
| -2% | -$8.7K | 0.04% | 174 |
|
|
2025
Q2 | $539K | Sell |
1,930
-205
| -10% | -$58.1K | 0.04% | 197 |
|
|
2025
Q1 | $665K | Sell |
2,135
-18
| -0.8% | -$5.32K | 0.05% | 169 |
|
|
2024
Q4 | $561K | Sell |
2,153
-75
| -3% | -$22.3K | 0.04% | 175 |
|
|
2024
Q3 | $718K | Hold |
2,228
| – | – | 0.05% | 155 |
|
|
2024
Q2 | $696K | Sell |
2,228
-85
| -4% | -$25K | 0.06% | 156 |
|
|
2024
Q1 | $658K | Hold |
2,313
| – | – | 0.06% | 165 |
|
|
2023
Q4 | $666K | Buy |
2,313
+25
| +1% | +$6.81K | 0.06% | 158 |
|
|
2023
Q3 | $615K | Sell |
2,288
-141
| -6% | -$35.2K | 0.07% | 156 |
|
|
2023
Q2 | $539K | Sell |
2,429
-370
| -13% | -$85.9K | 0.06% | 162 |
|
|
2023
Q1 | $677K | Buy |
2,799
+394
| +16% | +$96.7K | 0.07% | 151 |
|
|
2022
Q4 | $632K | Sell |
2,405
-170
| -7% | -$45.6K | 0.07% | 153 |
|
|
2022
Q3 | $580K | Buy |
2,575
+285
| +12% | +$69.1K | 0.07% | 161 |
|
|
2022
Q2 | $557K | Sell |
2,290
-156
| -6% | -$38.2K | 0.07% | 168 |
|
|
2022
Q1 | $591K | Sell |
2,446
-261
| -10% | -$60K | 0.07% | 172 |
|
|
2021
Q4 | $609K | Sell |
2,707
-83
| -3% | -$17.5K | 0.08% | 145 |
|
|
2021
Q3 | $593K | Sell |
2,790
-25
| -0.9% | -$5.75K | 0.09% | 142 |
|
|
2021
Q2 | $686K | Sell |
2,815
-79
| -3% | -$19.4K | 0.11% | 127 |
|
|
2021
Q1 | $720K | Buy |
2,894
+412
| +17% | +$98.3K | 0.12% | 117 |
|
|
2020
Q4 | $571K | Buy |
2,482
+190
| +8% | +$43.8K | 0.11% | 124 |
|
|
2020
Q3 | $583K | Buy |
2,292
+50
| +2% | +$12.4K | 0.13% | 119 |
|
|
2020
Q2 | $529K | Buy |
2,242
+242
| +12% | +$55.2K | 0.13% | 123 |
|
|
2020
Q1 | $405K | Buy |
2,000
+593
| +42% | +$130K | 0.11% | 128 |
|
|
2019
Q4 | $339K | Buy |
1,407
+110
| +8% | +$24.2K | 0.08% | 145 |
|
|
2019
Q3 | $251K | Sell |
1,297
-615
| -32% | -$118K | 0.06% | 161 |
|
|
2019
Q2 | $352K | Buy |
+1,912
| New | +$342K | 0.09% | 142 |
|
|
2016
Q4 | – | Sell |
-386
| Closed | -$64K | – | 203 |
|
|
2016
Q3 | $64K | Buy |
+386
| New | +$65.3K | 0.02% | 235 |
|
|
2016
Q2 | – | Sell |
-291
| Closed | -$44K | – | 195 |
|
|
2016
Q1 | $44K | Hold |
291
| – | – | 0.01% | 272 |
|
|
2015
Q4 | $47K | Buy |
291
+250
| +610% | +$39.3K | 0.01% | 268 |
|
|
2015
Q3 | $6K | Sell |
41
-50
| -55% | -$7.88K | ﹤0.01% | 455 |
|
|
2015
Q2 | $14K | Buy |
+91
| New | +$14.6K | ﹤0.01% | 388 |
|
Other funds holding AMGN
FFM
Woodmont Investment Counsel's AMGN Position: Q2 2026 in Review
Woodmont Investment Counsel increased its Amgen (AMGN) stake by 0.28% in Q2 2026, buying an estimated $1.71K and bringing the position to 1,805 shares worth $654K. The position accounts for 0.04% of the portfolio, ranked #169.
Woodmont Investment Counsel first reported a position in AMGN in Q2 2015 and has held it in 34 quarters since. The position peaked at $720K in Q1 2021. 1,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Woodmont Investment Counsel held 1,805 shares of Amgen worth $654K as of Q2 2026.
- Woodmont Investment Counsel bought 5 Amgen shares in Q2 2026, an estimated $1.71K.
- Amgen made up 0.04% of Woodmont Investment Counsel's portfolio in Q2 2026, its #169 holding.
- Woodmont Investment Counsel first reported a position in Amgen in Q2 2015 and has held it in 34 quarters since.
- Woodmont Investment Counsel's Amgen position peaked at $720K in Q1 2021.
- 1,390 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Woodmont Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.